Video

From dysbiosis to long-term outcomes: Flavia Indrio wraps up PPPP 2026

Prof. Flavia Indrio reflects on the main take-home messages from the congress, which brought together 32 leading international experts in microbiota research, allergy, nutrition, gut-brain axis and lung disease.

When microbiomes turn risky: a one health view of infective competence

Paul Wilmes, University of Luxembourg, explores the concept of infective competence within a One Health framework.

A whole-tomato approach to functional nutrition, inflammation, and microbiome modulation

Piergiorgio Natali (Mediterranean Task force for Cancer Control) discusses the importance of improving functional foods as a strategy to support health, particularly during aging.

Beyond sequencing: the role of translational research in functional microbiome profiling

Lorenza Putignani, Pediatric Hospital Bambino Gesù, Italy, discusses translational research in the microbiome field.

The gut microbiome: emerging therapeutic perspectives in multiple sclerosis and type 1 diabetes

Marika Falcone of San Raffaele Hospital in Milan discusses the growing evidence linking the gut microbiome to extra-intestinal autoimmune diseases.

Microbiome innovation meets space exploration: a new frontier for human adaptation

Pierre Burguière, founder of Microbiome Futures, and Christian Roghi, founder of Bridgyz, reflect on a groundbreaking Pharmabiotics 2026 session dedicated to the intersection of microbiome science and space exploration.

IBD and the microbiome: between biological complexity and emerging therapeutic signals

Maurizio Vecchi, gastroenterologist at Policlinico of Milan (Italy), discussed the current and potential role of the microbiome in inflammatory bowel disease (IBD).

Oral Microbiome: a new window on systemic health—and a clinical opportunity for evidence-based probiotics

Gianfranco Grompone, Chief Scientific Officer at BioGaia GA, discusses the new evidences about oral microbiome.

Pregnancy: how dysbiosis may affect placentation, maternal immunity, and the risk of neonatal sepsis

Maria Rescigno (Humanitas University, Rozzano, Milan) discusses the role of dysbiosis during pregnancy and the perinatal period, outlining two potential clinical trajectories.

Postbiotics: the story, the evidences, the ingredient

How postbiotics are reshaping dietary supplements and pharma: key insights from Humiome® Post LB.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.